Williams T, Mishra R, Bharkhada B, Shields A, et al. Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study. J Neurol Neurosurg Psychiatry 2022 Mar 10. pii: jnnp-2021-328340.
PMID: 35273069